Related Experiment Video
Updated: May 5, 2026
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Management of diabetes mellitus in infants
Beate Karges1, Thomas Meissner, Andrea Icks
1Division of Endocrinology and Diabetes, RWTH Aachen University, Pauwelsstraße 30, D-52074 Aachen, Germany. bkarges@ukaachen.de
Insights
Neonatal diabetes mellitus (NDM) has unique causes and treatments compared to older children. Early diagnosis and specialized care, including genetic testing and tailored insulin therapy, are crucial for infants with NDM.
Area of Science:
- Pediatrics
- Endocrinology
- Genetics
Background:
- Diabetes mellitus in infants presents distinct challenges from older children.
- Recent advances have identified genetic causes like monogenic beta-cell defects and 6q24 abnormalities in neonatal diabetes mellitus.
- Infants require specialized care due to their complete dependence on caregivers.
Purpose of the Study:
- To outline the unique aspects of diabetes mellitus diagnosed in the first two years of life.
- To discuss the evolving genetic causes and treatment modalities for neonatal diabetes mellitus.
- To emphasize the importance of education and psychosocial support for caregivers of infants with diabetes.
Main Methods:
- Review of recent literature on neonatal diabetes mellitus.
- Analysis of genetic causes, including KCNJ11 and ABCC8 mutations.
- Evaluation of treatment options such as oral sulfonylureas and continuous subcutaneous insulin infusion.
- Assessment of care requirements, including education and psychosocial support.
Main Results:
- Monogenic beta-cell defects and 6q24 abnormalities are key genetic causes of neonatal diabetes mellitus.
- Oral sulfonylurea is effective for KCNJ11 or ABCC8 mutations.
- Infants with type 1 diabetes mellitus show faster onset and poorer beta-cell function.
- Continuous subcutaneous insulin infusion shows promise for infants.
- Caregiver education and psychosocial support are vital for infant diabetes management.
Conclusions:
- Neonatal diabetes mellitus requires a distinct approach from diabetes in older children.
- Genetic testing and tailored therapies, including sulfonylureas or advanced insulin delivery, are critical.
- Multidisciplinary care and robust caregiver support are essential for optimal outcomes in infants with diabetes.
Abstract:
Diabetes mellitus diagnosed during the first 2 years of life differs from the disease in older children regarding its causes, clinical characteristics, treatment options and needs in terms of education and psychosocial support. Over the past decade, new genetic causes of neonatal diabetes mellitus have been elucidated, including monogenic β-cell defects and chromosome 6q24 abnormalities. In patients with KCNJ11 or ABCC8 mutations and diabetes mellitus, oral sulfonylurea offers an easy and effective treatment option. Type 1 diabetes mellitus in infants is characterized by a more rapid disease onset, poorer residual β-cell function and lower rate of partial remission than in older children. Insulin therapy in infants with type 1 diabetes mellitus or other monogenic causes of diabetes mellitus is a challenge, and novel data highlight the value of continuous subcutaneous insulin infusion in this very young patient population. Infants are entirely dependent on caregivers for insulin therapy, nutrition and glucose monitoring, which emphasizes the need for appropriate education and psychosocial support of parents. To achieve optimal long-term metabolic control with low rates of acute and chronic complications, continuous and structured diabetes care should be provided by a multidisciplinary health-care team.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:15Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:16Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:26Diabetes Mellitus: Introduction